PCNA and colonic neoplasm: elucidated that SIT triggers dose-dependent growth inhibition of human colon cancer COLO 320D cells by scavenging ROS, inducing apoptosis, and inhibiting the expression of β-catenin and PCNA antigens in human colon cancer cells (51).